"Medipol Mega Üniversite Hastanesi, bireylerin yaşam kalitesini artırmak adına önleyici ve tedavi edici sağlık hizmetlerini geliştirmeye yönelik önemli adımlar atmaya devam etmektedir."

During the past decade, Istanbul Medipol University Hospital conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Istanbul Medipol University Hospital" #1 sponsor was "Medipol University" with 38 trials, followed by "Istanbul Medipol University Hospital" with 7 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Farzin Hajebrahimi, PT, MSc" with 1 trials sponsored and "Mahmut Gumus" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istanbul Medipol University Hospital" #1 collaborator was "Alanya Alaaddin Keykubat University" with 1 trials as a collaborator, "Istanbul Medipol University Hospital" with 1 trials as a collaborator, "KTH Royal Institute of Technology" with 1 trials as a collaborator, "Sahlgrenska University Hospital, Sweden" with 1 trials as a collaborator and "ScandiBio Therapeutics AB" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Istanbul Medipol University Hospital" are "Lumbar Disc Herniation" (5 trials), "Lung Diseases" (4 trials), "Breast Cancer" (3 trials), "Breast Neoplasms" (3 trials) and "Breast Diseases" (2 trials). Many other conditions were trialed in "Istanbul Medipol University Hospital" in a lesser frequency.

Most popular intervention types in "Istanbul Medipol University Hospital" are "Other" (34 trials), "Drug" (13 trials), "Behavioral" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Erector spinae plane block (Group E)" (5 trials), "Postoperative analgesia management" (4 trials), "Dexamethasone" (3 trials), "Teclistamab" (3 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Istanbul Medipol University Hospital" are 47 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Istanbul Medipol University Hospital". undefined are not yet recruiting, 13 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Istanbul Medipol University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Istanbul Medipol University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 40 trials that are defined as “Not Applicable".